Clinical practice. Postmenopausal osteoporosis. [N Engl J Med. 2005] - PubMed

Review Post-menopausal osteoporosis. [Best Pract Res Clin Obstet Gynaecol. 2002]
Review Post-menopausal osteoporosis.
Marcus R. Best Pract Res Clin Obstet Gynaecol. 2002 Jun; 16(3):309-27.
Guidelines for the management of postmenopausal osteoporosis for GPs. [Aust Fam Physician. 2004]
Guidelines for the management of postmenopausal osteoporosis for GPs.
O'Neill S, MacLennan A, Bass S, Diamond T, Ebeling P, Findlay D, Flicker L, Markwell A, Nowson C, Pocock N, et al. Aust Fam Physician. 2004 Nov; 33(11):910-9.
Review Treating osteoporosis without hormones. [Orthop Nurs. 2002]
Review Treating osteoporosis without hormones.
Turkoski B. Orthop Nurs. 2002 Sep-Oct; 21(5):80-5.
Review Drugs for prevention and treatment of postmenopausal osteoporosis. [Treat Guidel Med Lett. 2005]
Review Drugs for prevention and treatment of postmenopausal osteoporosis.
. Treat Guidel Med Lett. 2005 Oct; 3(38):69-74.
Review Preventing osteoporosis-related fractures: an overview. [Am J Med. 2006]
Review Preventing osteoporosis-related fractures: an overview.
Gass M, Dawson-Hughes B. Am J Med. 2006 Apr; 119(4 Suppl 1):S3-S11.

A novel mutation in the calcium-sensing receptor gene in an Irish pedigree showing familial hypocalciuric hypercalcemia: a case report. [J Med Case Reports. 2010]
A novel mutation in the calcium-sensing receptor gene in an Irish pedigree showing familial hypocalciuric hypercalcemia: a case report.
Elamin WF, de Buyl O. J Med Case Reports. 2010 Oct 29; 4:349. Epub 2010 Oct 29.
Bisphosphonates for osteoporosis treatment are associated with reduced breast cancer risk. [Br J Cancer. 2010]
Bisphosphonates for osteoporosis treatment are associated with reduced breast cancer risk.
Newcomb PA, Trentham-Dietz A, Hampton JM. Br J Cancer. 2010 Mar 2; 102(5):799-802. Epub 2010 Feb 16.
Endogenous n-3 fatty acids protect ovariectomy induced bone loss by attenuating osteoclastogenesis. [J Cell Mol Med. 2009]
Endogenous n-3 fatty acids protect ovariectomy induced bone loss by attenuating osteoclastogenesis.
Rahman MM, Bhattacharya A, Banu J, Kang JX, Fernandes G. J Cell Mol Med. 2009 Aug; 13(8B):1833-44.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

Clinical practice. Postmenopausal osteoporosis.
Clinical practice. Postmenopausal osteoporosis.
N Engl J Med. 2005 Aug 11 ;353(6):595-603.

PubMed
Dual and pan-peroxisome proliferator-activated receptors (PPAR) co-agonism: the ...
Dual and pan-peroxisome proliferator-activated receptors (PPAR) co-agonism: the bezafibrate lessons.
Cardiovasc Diabetol. 2005 Sep 16 ;4:14.

PubMed
Clinical practice. Paget's disease of bone.
Clinical practice. Paget's disease of bone.
N Engl J Med. 2006 Aug 10 ;355(6):593-600.

PubMed
The cortico-basal ganglia integrative network: the role of the thalamus.
The cortico-basal ganglia integrative network: the role of the thalamus.
Brain Res Bull. 2009 Feb 16 ;78(2-3):69-74. Epub 2008 Oct 23 .

PubMed
Tectonigral projections in the primate: a pathway for pre-attentive sensory inpu...
Tectonigral projections in the primate: a pathway for pre-attentive sensory input to midbrain dopaminergic neurons.
Eur J Neurosci. 2009 Feb ;29(3):575-87. Epub 2009 Jan 17 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed